Article info

Download PDFPDF

Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

Authors

  • Evan J. Lipson Department of OncologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg ~ Kimmel Institute for Cancer Immunotherapy Baltimore MD USA Melanoma and Cancer Immunology Programs, Johns Hopkins University School of Medicine 1550 Orleans Street, Room 507 21231 Baltimore MD USA PubMed articlesGoogle scholar articles
  • Mohammed T. Lilo Department of PathologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg ~ Kimmel Institute for Cancer Immunotherapy Baltimore MD USA PubMed articlesGoogle scholar articles
  • Aleksandra Ogurtsova Department of DermatologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg ~ Kimmel Institute for Cancer Immunotherapy Baltimore MD USA PubMed articlesGoogle scholar articles
  • Jessica Esandrio Department of PathologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg ~ Kimmel Institute for Cancer Immunotherapy Baltimore MD USA PubMed articlesGoogle scholar articles
  • Haiying Xu Department of DermatologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg ~ Kimmel Institute for Cancer Immunotherapy Baltimore MD USA PubMed articlesGoogle scholar articles
  • Patricia Brothers Department of OncologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg ~ Kimmel Institute for Cancer Immunotherapy Baltimore MD USA PubMed articlesGoogle scholar articles
  • Megan Schollenberger Department of OncologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg ~ Kimmel Institute for Cancer Immunotherapy Baltimore MD USA PubMed articlesGoogle scholar articles
  • William H. Sharfman Department of OncologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg ~ Kimmel Institute for Cancer Immunotherapy Baltimore MD USA PubMed articlesGoogle scholar articles
  • Janis M. Taube Department of OncologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg ~ Kimmel Institute for Cancer Immunotherapy Baltimore MD USA Department of PathologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg ~ Kimmel Institute for Cancer Immunotherapy Baltimore MD USA Department of DermatologyJohns Hopkins University School of Medicine, Sidney Kimmel Comprehensive Cancer Center, and Bloomberg ~ Kimmel Institute for Cancer Immunotherapy Baltimore MD USA PubMed articlesGoogle scholar articles
  1. a 410-502-5977 evanlipson{at}jhmi.edu
  2. b mlilo1{at}jhmi.edu
  3. c aogurts1{at}jhmi.edu
  4. d jesandr1{at}jhmi.edu
  5. e hxu12{at}jhmi.edu
  6. f pbrothe1{at}jhmi.edu
  7. g mscholl3{at}jhmi.edu
  8. h sharfwi{at}jhmi.edu
  9. i jtaube1{at}jhmi.edu
View Full Text

Citation

Lipson EJ, Lilo MT, Ogurtsova A, et al
Basal cell carcinoma: PD-L1/PD-1 checkpoint expression and tumor regression after PD-1 blockade

Publication history

  • Received January 10, 2017
  • Accepted February 17, 2017
  • First published March 21, 2017.
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.